Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Clinical trial NCT00025181 · COMPLETED

Trial details

NCT number: NCT00025181
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2001-10-01
Primary completion: 2003-01-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.